Innovative Diagnostic Technology LexaGene offers a cutting-edge, fully automated PCR-based system capable of detecting multiple pathogens simultaneously, making it highly attractive to laboratories seeking rapid, comprehensive testing solutions across clinical, veterinary, and food safety markets.

Expanding Market Potential With a focus on open-access custom testing markets needing critical answers in less time, there are opportunities to introduce LexaGene’s MiQLab System to industries such as agriculture, public health, and drug development, broadening its commercial reach.

Growth Funding and Revenue Having secured over five million dollars in funding and generating up to ten million dollars in revenue, LexaGene is positioned to accelerate product development and expand sales channels, creating openings for technology deployment in new and emerging markets.

Focused Industry Niche Targeting relatively small but specialized markets such as veterinary diagnostics and food safety allows for tailored sales strategies and personalized offerings to niche customers who prioritize rapid and sensitive pathogen detection.

Technology and Infrastructure Utilizing diverse cloud and enterprise software tools indicates a modern technological infrastructure, enabling scalable solutions and data management that can support large-scale deployments and facilitate customer integration in various industries.